The IPO Buzz: Electra Therapeutics (ETRA Proposed) Sets Terms for $325 Million IPO
Electra Therapeutics (ETRA proposed), a late-stage biotech focused on cancer and autoimmune disorders, set the terms early today for its IPO: 21.67 million shares at a price range of $14.00 to $16.00 to raise $325.05 million, if priced at the $15.00 mid-point of its range, according to its S-1/A filing dated Sept. 14, 2026. The San Francisco-based biotech would have a market cap of $916.5 million..
Read more September 14, 2026IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| American Savings Bank of Hawaii | ASBH | 7.5 | $ 120.0 mil | 9/16/2026 Wednesday | S/O | S/O |
| Electra Therapeutics | ETRA | 21.7 | $ 325.1 mil | 9/18/2026 Friday | S/O | S/O |
| Holtec Nuclear Corp. | HNUC | 50.0 | $ 825.0 mil | 9/18/2026 Friday | S/O | S/O |
Last 100 IPOs - September 14, 2026
| Number of IPOs priced : | 100 |
| Number Up: | 50 |
| Number Down: | 49 |
| Number Unchanged: | 1 |
| Percentage Change From Issue Price: | 9.03% |
| Percentage Change for The Nasdaq Composite | 35.22% |
2026 IPO Scorecard - September 14, 2026
| Number of IPOs priced (Excluding 145 units) : | 119 |
| Number Up: | 58 |
| Number Down: | 60 |
| Number Unchanged: | 1 |
| Total Return From Issue Price: | 8.60% |
| The Nasdaq Composite Index YTD % Change | 35.22% |